Diagnosing Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Ultrasound Diagnostic Criteria

For individuals aged 15-39 years with a positive family history, the American College of Radiology recommends diagnosis confirmation with ≥3 total kidney cysts and diagnosis ruled out with ≤1 kidney cyst 1, 2, 3
For individuals aged 40-59 years with a positive family history, diagnosis is confirmed with ≥2 cysts in each kidney and ruled out with ≤2 cysts total 1, 2, 3
For individuals aged ≥60 years with a positive family history, diagnosis is confirmed with ≥4 cysts in each kidney 1, 2, 3

The National Kidney Foundation suggests starting with abdominal ultrasound as first-line imaging for adults with a positive family history 1, 3
Age-specific ultrasound criteria should be applied as outlined above for adults with a positive family history 1, 2
If results are equivocal or atypical, proceeding to MRI or genetic testing is recommended 1, 3
For genetically resolved families, targeted genetic testing for the specific family variant is usually sufficient 2

The American Society of Nephrology notes that these ultrasound and MRI criteria apply only to families with pathogenic variants of PKD1 or PKD2 2
Genetic testing is particularly valuable in cases with few kidney cysts, variable intrafamilial disease severity, discordant imaging and glomerular filtration rate, negative family history, or young living-related kidney donors at risk of ADPKD 2, 3
The Mayo Imaging Classification can be used to predict future decline in kidney function and timing of kidney failure in patients with confirmed ADPKD 2

Several inherited diseases may mimic ADPKD with kidney and/or liver cysts 2
The severity of ADPKD varies based on the causal gene, type of PKD1 mutation, sex, and environmental factors 2

For individuals aged 16-40 years with a positive family history of ADPKD, the presence of >10 total kidney cysts on MRI confirms the diagnosis, while <5 total cysts rules out ADPKD 4, 5, 6
The American Academy of Nephrology recommends that children <15 years with a positive family history, one or more kidney cysts is highly suggestive of ADPKD 7, 8

The National Institute of Diabetes and Digestive and Kidney Diseases suggests starting with ultrasound as first-line imaging for screening, and proceeding to MRI when ultrasound results are equivocal or atypical, or when additional prognostic information is needed 4, 5, 8
The European Renal Association states that MRI criteria apply only to families with PKD1 or PKD2 mutations, not to those with minor gene variants 4, 5, 6

The Mayo Clinic recommends using the Mayo Imaging Classification (MIC) to stratify patients with typical imaging into 5 groups (1A-1E), indicating accelerating decline in kidney function 4, 9
The American College of Radiology suggests that MRI is the preferred modality for measuring total kidney volume accurately, using automated or semi-automated tools 4, 9

In children < 15 years with a known family history of ADPKD, detection of ≥ 1 renal cyst on ultrasound is highly suggestive of disease. 10
The specificity of a single cyst on ultrasound in this age group is 89 % for children < 5 years and 100 % for children ≥ 5 years. 10
In fetuses or neonates with a positive family history, hyperechogenic kidneys and/or kidneys enlarged > 2 standard deviations on prenatal ultrasound are indicative of ADPKD. 10
A single cyst in a child should not be taken as definitive proof of ADPKD; rare cases have failed confirmation on follow‑up. 10

A normal ultrasound does not exclude ADPKD in at‑risk individuals < 40 years; the negative predictive value is ≈ 90 % for ages 18‑29 years. 10, 11
After age 40, a normal ultrasound can exclude disease with near‑100 % certainty in first‑degree relatives. 11
Because cysts develop gradually—especially in milder PKD2 phenotypes—early ultrasounds may miss disease; therefore, repeat screening at intervals of ≥ 3 years is advised when the initial study is normal. 10

For donors aged 20‑30 years, a negative ultrasound does not rule out ADPKD; donation should not proceed based on ultrasound alone, and genetic testing is recommended. 12
For donors > 30 years, proceeding with donation is considered safe if ultrasound shows no cysts. 12

MRI provides greater sensitivity than ultrasound for detecting small renal cysts in individuals aged 16‑40 years, especially in teenagers and young adults. 13, 14
In this age group, the presence of > 10 total kidney cysts on MRI confirms ADPKD, whereas < 5 cysts effectively rules out the disease. 15

A multigene panel that includes PKD1, PKD2, PKHD1, HNF1B, DZIP1L and other ciliopathy genes is recommended over single‑gene testing for comprehensive molecular diagnosis. 13, 16, 14
Indications for genetic testing (supported by evidence) include:
Inherited disorders that can mimic ADPKD (e.g., HNF1B‑related disease, Alagille syndrome, TSC2 contiguous‑gene deletions) are more accurately distinguished by broad genetic panel testing than by imaging alone. 13, 16, 15

Once ADPKD is confirmed, height‑adjusted total kidney volume measured by MRI or CT is used in the Mayo Imaging Classification (MIC) to stratify risk; class 1 disease (typical PKD1/PKD2) is divided into five groups (1A‑1E) that predict the speed of kidney function decline. 15
The MIC is validated only for PKD1 and PKD2 mutations and should not be applied to cases caused by minor‑gene variants. 15